The United Kingdom has become the first country to officially approve a gene therapy treatment for sickle cell disease and thalassemia.
The regulatory agency in Britain has approved the first-ever gene therapy for sickle cell disease, potentially providing relief to numerous individuals suffering from this debilitating condition in the United Kingdom. On Thursday, the Medicines and Healthcare Regulatory Agency announced that they have granted approval for Casgevy, the first medication to be licensed using the CRISPR
READ MORE